Research Article

MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2

Table 2

Patients’ characteristics and PHF2 expression. P values are obtained from χ2 test.

VariablesPHF2 staining
High (%)Low (%)TotalP

All points23 (38.3)37 (61.7)60
Age
 ≤57 years5 (33.3)10 (66.7)150.646
 >57 years18 (40.0)27 (60.0)45
Gender
 Male16 (41.0)23 (59.0)390.559
 Female7 (33.3)14 (66.7)21
Tumor size
 ≤7cm13 (27.9)25 (72.1)380.388
 >7cm10 (34.5)12 (65.5)22
pT status
 p8 (61.5)5 (38.5)130.013
 pT312 (46.2)14 (53.8)26
 pT43 (14.3)18 (85.7)21
pN status
 pN010 (58.8) 7 (41.2)170.032
 pN18(44.4)10 (55.6)18
 pN2-pN35 (20.0) 20 (80.0)25
TNM stage
 II13 (56.5)10 (43.5)230.022
 III-IV10 (27.0)27 (73.0)37
Serum AFP
 ≤400μg/L14(53.8)12(46.2)260.031
 >400μg/L9(26.5)25(73.5)34
Microvascular invasion
 Yes12(37.5)20(62.5)320.887
 No11(39.3)17(60.7)28
Portal vein tumor thrombus
 Yes13(41.9)18(58.1)310.553
 No10(34.5)19(65.5)29